Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 50 entries
View as:

Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)

Phase: N/A Priority: Normal
NCT ID: NCT00093886 Org: User:
Start: 04/30/04 End: 04/30/05 Due: 04/30/06

Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF

Phase: N/A Priority: Normal
NCT ID: NCT04592380 Org: User:
Start: 08/31/14 End: 11/30/16 Due: 11/30/17

Study to Investigate the Safety and Efficacy of 3 Dosing Regimens of ABP-700 for Procedural Sedation in Adult Participants Undergoing Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT02800590 Org: User:
Start: 05/31/16 End: 06/30/17 Due: 06/30/18

Cangrelor to Clopidogrel or Prasugrel Transition Study

Phase: N/A Priority: Normal
NCT ID: NCT01979445 Org: User:
Start: 12/02/13 End: 01/20/14 Due: 01/20/15

Bivalirudin as a Procedural Anticoagulant in Pediatrics

Phase: N/A Priority: Normal
NCT ID: NCT00503126 Org: User:
Start: 08/31/07 End: 07/31/08 Due: 07/31/09

Utilisation of Angiox® in European Practice

Phase: N/A Priority: Normal
NCT ID: NCT01011504 Org: User:
Start: 05/31/09 End: 12/31/10 Due: 12/31/11

Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB

Phase: N/A Priority: Normal
NCT ID: NCT00073593 Org: User:
Start: 08/31/03 End: - Due: -

Assess the Effect of Cangrelor at the Therapeutic Dose and a Supratherapeutic Dose Level on the QT/QTc Interval in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00699504 Org: User:
Start: 06/30/08 End: 11/30/08 Due: 11/30/09

Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01530399 Org: User:
Start: 03/31/12 End: 11/30/12 Due: 11/30/13

Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor

Phase: N/A Priority: Normal
NCT ID: NCT00102674 Org: User:
Start: 03/31/05 End: 05/31/05 Due: 05/31/06

A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)

Phase: N/A Priority: Normal
NCT ID: NCT01156571 Org: User:
Start: 09/30/10 End: 12/31/12 Due: 12/31/13

A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)

Phase: N/A Priority: Normal
NCT ID: NCT03159416 Org: User:
Start: 06/22/17 End: 03/24/18 Due: 03/24/19

MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial

Phase: N/A Priority: Normal
NCT ID: NCT02678923 Org: User:
Start: 12/03/15 End: 10/26/16 Due: 10/26/17

Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants

Phase: N/A Priority: Normal
NCT ID: NCT02395653 Org: User:
Start: 06/29/15 End: 09/12/16 Due: 09/12/17

Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT03400800 Org: User:
Start: 11/01/17 End: 08/27/19 Due: 08/27/20

Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)

Phase: N/A Priority: Normal
NCT ID: NCT00799604 Org: User:
Start: 11/30/08 End: 10/31/09 Due: 10/31/10

Maintenance of Platelet Inhibition With Cangrelor

Phase: N/A Priority: Normal
NCT ID: NCT00767507 Org: User:
Start: 10/31/08 End: 07/31/11 Due: 07/31/12

Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH

Phase: N/A Priority: Normal
NCT ID: NCT01651780 Org: User:
Start: 10/31/12 End: 06/30/15 Due: 06/30/16

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00759083 Org: User:
Start: 09/30/08 End: 05/10/10 Due: 05/10/11

Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)

Phase: N/A Priority: Normal
NCT ID: NCT00093158 Org: User:
Start: 08/31/03 End: 01/31/07 Due: 01/31/08

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

Phase: N/A Priority: Normal
NCT ID: NCT00079508 Org: User:
Start: 04/30/04 End: - Due: -

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02471690 Org: User:
Start: 07/31/15 End: 04/30/16 Due: 04/30/17

Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)

Phase: N/A Priority: Normal
NCT ID: NCT00803634 Org: User:
Start: 12/31/08 End: 03/31/12 Due: 03/31/13

ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial

Phase: N/A Priority: Normal
NCT ID: NCT01913483 Org: User:
Start: 09/24/13 End: 03/16/16 Due: 03/16/17

Cangrelor Ticagrelor Transition Study

Phase: N/A Priority: Normal
NCT ID: NCT01766466 Org: User:
Start: 01/31/13 End: 02/28/13 Due: 02/28/14